Pharmacological or genetic ablation of CB1 in diet-induced and genetic mouse models of obesity results in a transient hypophagic response, followed by prolonged effects on weight loss, adiposity, and normalization of metabolic parameters [13], [14], [15], [16], [17], [18]. The gene discussed is CNR1; the disease is obesity disorder.